Yukio Tsunoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yukio Tsunoda has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Yoko Kato
14 shared publicationsY Kato
Laboratory of Animal Reproduction, College of Agriculture, Kinki University, 3327-204, Nakamachi, Nara, 631-8505, Japan
4 shared publicationsY. Kato
4 shared publicationsTetsuya Tani
Laboratory of Animal Reproduction, College of Agriculture, Kinki University, Nakamachi, Nara, Japan
3 shared publicationsYuta Tsuji
3 shared publicationsT. Tani
Laboratory of Animal Reproduction, College of Agriculture, Kinki University, Nara, 631‐8505, Japan
2 shared publications
Latest Publications
- 1 October 2012
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 29 (3) , 128-134
Effects of Rizoma Arisaematis, a Traditional Chinese Natural Medicine, on In Vitro Development of Mouse In Vivo Zygotes and Embryos Produced by Intracytoplasmic Sperm Injection and Somatic Cell Nuclear Transfer
After screening 408 crude drugs, we found that Rizoma Arisaematis increased the cell numbers of mouse blastocysts developed from in vivo zygotes. We examined the effects of Rizoma Arisaematis on the in vitro development of mouse zygotes and embryos produced by ICSI and SCNT, as well as on fetal development. Mouse zygotes were cultured in media containing a water-soluble extract of Rizoma Arisaematis at various concentrations, and the potential of zygotes to develop into blastocysts and the cell numbers of blastocysts were examined. In addition, the effects of Rizoma Arisaematis on the in vitro and in vivo developmental potential of embryos produced by ICSI and nuclear transfer were examined. In vitro treatment of zygotes with Rizoma Arisaematis increased the cell numbers of blastocysts. The proportions of the blastocysts that implanted and developed into fetuses were slightly higher in the blastocysts which were developed from zygotes treated with Rizoma Arisaematis than those of the control. Th...
- 1 October 2012
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 29 (3) , 128-134
Effects of Rizoma Arisaematis, a Traditional Chinese Natural Medicine, on In Vitro Development of Mouse In Vivo Zygotes and Embryos Produced by Intracytoplasmic Sperm Injection and Somatic Cell Nuclear Transfer
After screening 408 crude drugs, we found that Rizoma Arisaematis increased the cell numbers of mouse blastocysts developed from in vivo zygotes. We examined the effects of Rizoma Arisaematis on the in vitro development of mouse zygotes and embryos produced by ICSI and SCNT, as well as on fetal development. Mouse zygotes were cultured in media containing a water-soluble extract of Rizoma Arisaematis at various concentrations, and the potential of zygotes to develop into blastocysts and the cell numbers of blastocysts were examined. In addition, the effects of Rizoma Arisaematis on the in vitro and in vivo developmental potential of embryos produced by ICSI and nuclear transfer were examined. In vitro treatment of zygotes with Rizoma Arisaematis increased the cell numbers of blastocysts. The proportions of the blastocysts that implanted and developed into fetuses were slightly higher in the blastocysts which were developed from zygotes treated with Rizoma Arisaematis than those of the control. Th...
- 1 April 2012
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 29 (1) , 75-81
The Effect of Berberine Treatment on the Reversibility of the Development of Mouse Zygotes and Gametes, and on the Fertilization and Subsequent Development
As reported previously, berberine, the main component extracted from Coptis rhizome and Phellodendron, has potential as a contraceptive for animals since berberine has a strong inhibitory effect on the in vitro development of mouse zygotes and on fetal development in vivo. The present study was undertaken to examine the effect of berberine treatment on the reversibility of the development of zygotes and gametes, and on the fertilization and subsequent development in the mouse. The reversibility of the berberine-induced inhibition of the development of mouse zygotes was dependent on the concentration used and treatment period. Berberine treatment did not inhibit the fertilizing capacity of epididymal spermatozoa and the fertilizability of oocytes at the second metaphase stage. The present study demonstrated that in vitro development of mouse zygotes is about 100 times more sensitive to berberine than the in vitro growth of mouse fetal fibroblast cells. The high stability of berberine at low temperatures for at least for 12 months and the high sensitivity of preimplantation embryos to berberine is useful information when considering the administration of berberine to females as a contraceptive.
- 1 April 2012
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 29 (1) , 75-81
The Effect of Berberine Treatment on the Reversibility of the Development of Mouse Zygotes and Gametes, and on the Fertilization and Subsequent Development
As reported previously, berberine, the main component extracted from Coptis rhizome and Phellodendron, has potential as a contraceptive for animals since berberine has a strong inhibitory effect on the in vitro development of mouse zygotes and on fetal development in vivo. The present study was undertaken to examine the effect of berberine treatment on the reversibility of the development of zygotes and gametes, and on the fertilization and subsequent development in the mouse. The reversibility of the berberine-induced inhibition of the development of mouse zygotes was dependent on the concentration used and treatment period. Berberine treatment did not inhibit the fertilizing capacity of epididymal spermatozoa and the fertilizability of oocytes at the second metaphase stage. The present study demonstrated that in vitro development of mouse zygotes is about 100 times more sensitive to berberine than the in vitro growth of mouse fetal fibroblast cells. The high stability of berberine at low temperatures for at least for 12 months and the high sensitivity of preimplantation embryos to berberine is useful information when considering the administration of berberine to females as a contraceptive.
- 1 July 2011
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 20 (2) , 199-207
Effect of melatonin treatment on the developmental potential of parthenogenetic and somatic cell nuclear-transferred porcine oocytesin vitro
Summary: Melatonin secreted from the mammalian pineal gland is a free-radical scavenger that protects tissues from cell damage. The present study examined the effects of addition of melatonin to the culture medium on the developmental potential of parthenogenetic and somatic cell nuclear-transferred (SCNT) porcine oocytes. Supplementation of the maturation medium with melatonin did not increase the maturation rate, the proportion of oocytes that cleaved and developed into blastocysts after parthenogenetic activation, or the blastocyst cell number compared to controls. When 10−7M melatonin was added to the culture medium, the proportion of parthenogenetic oocytes that developed to the 2-cell and 4-cell stages was significantly higher than that of controls. The potential of melatonin-treated oocytes to develop into blastocysts was high but not significantly different from that of controls. The addition of 10−7M melatonin to the culture medium did not increase the preimplantation development of SCNT oocytes. Melatonin treatment significantly reduced the levels of reactive oxygen species in 4-cell parthenogenetic and SCNT embryos, but did not reduce the proportion of apoptotic cells in parthenogenetic and SCNT blastocysts. Although the results indicated that parthenogenetic and SCNT melatonin -treated embryos had significantly lower levels of reactive oxygen species than controls, the potential of melatonin-treated embryos to develop into blastocysts was not significantly higher than that of controls, in contrast to previous reports. The beneficial effects of melatonin on the developmental potential of oocytes might depend on the culture conditions.
- 1 July 2011
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 20 (2) , 199-207
Effect of melatonin treatment on the developmental potential of parthenogenetic and somatic cell nuclear-transferred porcine oocytesin vitro
Summary: Melatonin secreted from the mammalian pineal gland is a free-radical scavenger that protects tissues from cell damage. The present study examined the effects of addition of melatonin to the culture medium on the developmental potential of parthenogenetic and somatic cell nuclear-transferred (SCNT) porcine oocytes. Supplementation of the maturation medium with melatonin did not increase the maturation rate, the proportion of oocytes that cleaved and developed into blastocysts after parthenogenetic activation, or the blastocyst cell number compared to controls. When 10−7M melatonin was added to the culture medium, the proportion of parthenogenetic oocytes that developed to the 2-cell and 4-cell stages was significantly higher than that of controls. The potential of melatonin-treated oocytes to develop into blastocysts was high but not significantly different from that of controls. The addition of 10−7M melatonin to the culture medium did not increase the preimplantation development of SCNT oocytes. Melatonin treatment significantly reduced the levels of reactive oxygen species in 4-cell parthenogenetic and SCNT embryos, but did not reduce the proportion of apoptotic cells in parthenogenetic and SCNT blastocysts. Although the results indicated that parthenogenetic and SCNT melatonin -treated embryos had significantly lower levels of reactive oxygen species than controls, the potential of melatonin-treated embryos to develop into blastocysts was not significantly higher than that of controls, in contrast to previous reports. The beneficial effects of melatonin on the developmental potential of oocytes might depend on the culture conditions.
- 4 May 2011
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 20 (3) , 261-267
Administration of cyclosporin A to recipients improves the potential of mouse somatic cell nuclear-transferred oocytes to develop to fetuses
Summary: Somatic cell nuclear-transferred (SCNT) oocytes have a high potential for development in vitro, but a large proportion of embryos that are transferred to recipients is aborted before parturition. The precise mechanism for the high abortion rate is unknown, but abnormal placenta formation is frequently observed in SCNT-cloned pregnancies. The present study examined the effects of treating the recipients with cyclosporin A (CsA), an immunoprotectant, on the proportion of fetuses resulting from SCNT-cloned pregnancies. Cloned embryos developed from enucleated oocytes and receiving cumulus cells from F1 (C57BL/6 × DBA, H-2b/d) females were transferred to outbred ICR (in which the H-2 complex was not fixed) recipient females. Each recipient received an intraperitoneal injection of CsA or vehicle. Compared with vehicle, administration of CsA to recipients on day 4.5 of pregnancy significantly increased the proportion of fetuses observed on day 10.5. The proportion of fetuses at day 18.5 of pregnancy in recipients receiving CsA treatment was slightly higher than that in controls. This study is the first to report that CsA administration increases the proportion of fetuses resulting from SCNT-cloned pregnancies.
- 4 May 2011
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 20 (3) , 261-267
Administration of cyclosporin A to recipients improves the potential of mouse somatic cell nuclear-transferred oocytes to develop to fetuses
Summary: Somatic cell nuclear-transferred (SCNT) oocytes have a high potential for development in vitro, but a large proportion of embryos that are transferred to recipients is aborted before parturition. The precise mechanism for the high abortion rate is unknown, but abnormal placenta formation is frequently observed in SCNT-cloned pregnancies. The present study examined the effects of treating the recipients with cyclosporin A (CsA), an immunoprotectant, on the proportion of fetuses resulting from SCNT-cloned pregnancies. Cloned embryos developed from enucleated oocytes and receiving cumulus cells from F1 (C57BL/6 × DBA, H-2b/d) females were transferred to outbred ICR (in which the H-2 complex was not fixed) recipient females. Each recipient received an intraperitoneal injection of CsA or vehicle. Compared with vehicle, administration of CsA to recipients on day 4.5 of pregnancy significantly increased the proportion of fetuses observed on day 10.5. The proportion of fetuses at day 18.5 of pregnancy in recipients receiving CsA treatment was slightly higher than that in controls. This study is the first to report that CsA administration increases the proportion of fetuses resulting from SCNT-cloned pregnancies.
- 1 April 2011
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 28 (1) , 40-46
Coptis Rhizome and Phellodendron Bark Extracts and Berberine Inhibit the Development of Mouse Embryos
After screening 269 crude drugs for their ability to inhibit the development of mouse zygotes, we found Coptis rhizome and Phellodendron bark to have inhibitory effects. We examined the effects of both extracts and of berberine, a major component of these plants, on in vitro development of zygotes and on fullterm fetal development in the mouse. Mouse zygotes were cultured in medium containing water-soluble extracts of Coptis rhizome or Phellodendron bark, or berberine at various concentrations for 5 days and the potential of zygotes to develop to blastocysts was examined. In addition, superovulated mice were intramuscularly injected with berberine and mated, and examined for the in vivo development of fertilized eggs to blastocysts and full-term fetuses. In vitro development of zygotes to blastocysts was almost completely inhibited when they were cultured in medium containing more than 0.1 µg/ml Coptis rhizome, 10 µg/ml Phellodendron bark, or 0.01 µg/ml berberine chloride or berberine sulfate. When superovulated and mated females received 100 µg berberine chloride once a day for 2 to 14 days, the proportions of recovered blastocysts and full-term fetuses were significantly decreased. The present study indicates the potential use of berberine as a contraceptive for animals.
- 1 April 2011
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 28 (1) , 40-46
Coptis Rhizome and Phellodendron Bark Extracts and Berberine Inhibit the Development of Mouse Embryos
After screening 269 crude drugs for their ability to inhibit the development of mouse zygotes, we found Coptis rhizome and Phellodendron bark to have inhibitory effects. We examined the effects of both extracts and of berberine, a major component of these plants, on in vitro development of zygotes and on fullterm fetal development in the mouse. Mouse zygotes were cultured in medium containing water-soluble extracts of Coptis rhizome or Phellodendron bark, or berberine at various concentrations for 5 days and the potential of zygotes to develop to blastocysts was examined. In addition, superovulated mice were intramuscularly injected with berberine and mated, and examined for the in vivo development of fertilized eggs to blastocysts and full-term fetuses. In vitro development of zygotes to blastocysts was almost completely inhibited when they were cultured in medium containing more than 0.1 µg/ml Coptis rhizome, 10 µg/ml Phellodendron bark, or 0.01 µg/ml berberine chloride or berberine sulfate. When superovulated and mated females received 100 µg berberine chloride once a day for 2 to 14 days, the proportions of recovered blastocysts and full-term fetuses were significantly decreased. The present study indicates the potential use of berberine as a contraceptive for animals.
- 14 August 2009
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 18 (1) , 9-15
The effect of the time interval between injection and parthenogenetic activation on the spindle formation and the in vitro developmental potential of somatic cell nuclear-transferred rat oocytes
We examined the optimal conditions for somatic cell nuclear transfer (SCNT) in the rat. First, we examined the effect of preincubation time before activation on SCNT rat oocytes produced in the presence of MG132 with regard to spindle formation and the potential to develop into blastocysts. The spindles of SCNT oocytes continued to elongate with an increase in the culture duration and, in approximately half of oocytes, the chromosomes were distributed along the spindles at 120 min after incubation. Such abnormal spindle formation in SCNT oocytes is a possible reason for the low developmental potential of SCNT rat oocytes. To inhibit the formation of abnormal spindle formation, we examined secondly the developmental potential of rat SCNT oocytes that had been preincubated with nocodazole and demecolcine instead of MG132. The developmental rates in SCNT oocytes, however, were decreased. For successful rat somatic cell cloning, two steps might be required: (1) to culture the somatic cell nuclei for a sufficient time in MII oocyte cytoplasm to enhance nuclear reprogramming; and (2) to induce normal spindle formation with normal chromosomal construction.
- 14 August 2009
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 18 (1) , 9-15
The effect of the time interval between injection and parthenogenetic activation on the spindle formation and the in vitro developmental potential of somatic cell nuclear-transferred rat oocytes
We examined the optimal conditions for somatic cell nuclear transfer (SCNT) in the rat. First, we examined the effect of preincubation time before activation on SCNT rat oocytes produced in the presence of MG132 with regard to spindle formation and the potential to develop into blastocysts. The spindles of SCNT oocytes continued to elongate with an increase in the culture duration and, in approximately half of oocytes, the chromosomes were distributed along the spindles at 120 min after incubation. Such abnormal spindle formation in SCNT oocytes is a possible reason for the low developmental potential of SCNT rat oocytes. To inhibit the formation of abnormal spindle formation, we examined secondly the developmental potential of rat SCNT oocytes that had been preincubated with nocodazole and demecolcine instead of MG132. The developmental rates in SCNT oocytes, however, were decreased. For successful rat somatic cell cloning, two steps might be required: (1) to culture the somatic cell nuclei for a sufficient time in MII oocyte cytoplasm to enhance nuclear reprogramming; and (2) to induce normal spindle formation with normal chromosomal construction.
- 1 May 2009
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 17 (2) , 109-115
The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2′-deoxycytidine
Summary: To facilitate nuclear reprogramming, somatic cells or somatic cell nuclear-transferred (SCNT) oocytes have been treated with the histone deacetylase inhibitor trichostatin A (TSA), or the DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine (5-aza-dC), to relax epigenetic marks of differentiated somatic cells. TSA-treated SCNT oocytes have increased developmental potential, but the optimal treatment period is unknown. Reduced methylation levels in somatic cells have no positive effect on SCNT oocytes, but the treatment of SCNT embryos with 5-aza-dC has not been investigated. We examined the effect of TSA treatment duration on the developmental potential of mouse SCNT oocytes and the effect of 5-aza-dC treatment on their in vitro and in vivo developmental potential. To determine the effects of TSA treatment duration, nuclear-transferred (NT) oocytes were cultured for 0 to 26 h with 100 nM TSA. SCNT oocytes treated with TSA for 8 to 12 h had the higher rate of development to blastocysts and full-term fetuses were obtained after treatment for 8 to 12 h. When oocytes were treated for 14 h and 26 h, blastocyst rates were significantly decreased and fetuses were not obtained. To examine the effect of 5-aza-dC, 2-cell stage SCNT embryos were cultured with 10 or 100 nM 5-aza-dC for 48 h to the morula stage and transferred. The potential of embryos treated with 5-aza-dC to develop into blastocysts was decreased and no fetuses were obtained after transfer. The findings demonstrated that long-term TSA treatment of SCNT mouse oocytes and treatment with 5-aza-dC inhibit the potential to develop into blastocysts and to fetuses after transfer.
- 1 May 2009
- Published by Cambridge University Press (CUP) in Zygote
- Vol. 17 (2) , 109-115
The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2′-deoxycytidine
Summary: To facilitate nuclear reprogramming, somatic cells or somatic cell nuclear-transferred (SCNT) oocytes have been treated with the histone deacetylase inhibitor trichostatin A (TSA), or the DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine (5-aza-dC), to relax epigenetic marks of differentiated somatic cells. TSA-treated SCNT oocytes have increased developmental potential, but the optimal treatment period is unknown. Reduced methylation levels in somatic cells have no positive effect on SCNT oocytes, but the treatment of SCNT embryos with 5-aza-dC has not been investigated. We examined the effect of TSA treatment duration on the developmental potential of mouse SCNT oocytes and the effect of 5-aza-dC treatment on their in vitro and in vivo developmental potential. To determine the effects of TSA treatment duration, nuclear-transferred (NT) oocytes were cultured for 0 to 26 h with 100 nM TSA. SCNT oocytes treated with TSA for 8 to 12 h had the higher rate of development to blastocysts and full-term fetuses were obtained after treatment for 8 to 12 h. When oocytes were treated for 14 h and 26 h, blastocyst rates were significantly decreased and fetuses were not obtained. To examine the effect of 5-aza-dC, 2-cell stage SCNT embryos were cultured with 10 or 100 nM 5-aza-dC for 48 h to the morula stage and transferred. The potential of embryos treated with 5-aza-dC to develop into blastocysts was decreased and no fetuses were obtained after transfer. The findings demonstrated that long-term TSA treatment of SCNT mouse oocytes and treatment with 5-aza-dC inhibit the potential to develop into blastocysts and to fetuses after transfer.
- 12 July 2005
- Published by Wiley in Molecular Reproduction and Development
- Vol. 72 (2) , 152-160
Comparative analysis of development-related gene expression in mouse preimplantation embryos with different developmental potential
The potential of embryonic and somatic cell nuclear‐transferred (NT) mouse oocytes to develop into young is low compared with bovine NT oocytes. To examine the reasons for the low developmental potential of NT mouse oocytes, we analyzed the gene expression patterns of six development‐related genes (Oct4, Nanog, Stat3, stella, FGF4, and Sox2) during preimplantation development in manipulated oocytes with different potentials to develop into young using real‐time polymerase chain reaction (PCR) methods. The manipulated oocytes were parthenogenetically activated oocytes and embryonic stem cell, cumulus cell, morula blastomere NT oocytes, and in vitro‐cultured and in vivo‐recovered embryos. The mRNA expression patterns in mouse NT‐derived embryos markedly differed from in vivo and in vitro counterparts. Some transcript expression patterns in embryonic stem‐cell NT oocytes resembled those of parthenogenetic oocytes. Of the six developmentally important transcripts examined in NT embryos, four had a downregulated expression pattern at the blastocyst stage. Our findings indicate that abnormal expression patterns of development‐related genes during preimplantation development correlate with the low potential of NT oocytes to develop into young. Although more detailed information is required, Sox2 mRNA expression pattern in blastocysts seems to closely correlate with the developmental potential of NT embryos. Mol. Reprod. Dev.
- 12 July 2005
- Published by Wiley in Molecular Reproduction and Development
- Vol. 72 (2) , 152-160
Comparative analysis of development-related gene expression in mouse preimplantation embryos with different developmental potential
The potential of embryonic and somatic cell nuclear‐transferred (NT) mouse oocytes to develop into young is low compared with bovine NT oocytes. To examine the reasons for the low developmental potential of NT mouse oocytes, we analyzed the gene expression patterns of six development‐related genes (Oct4, Nanog, Stat3, stella, FGF4, and Sox2) during preimplantation development in manipulated oocytes with different potentials to develop into young using real‐time polymerase chain reaction (PCR) methods. The manipulated oocytes were parthenogenetically activated oocytes and embryonic stem cell, cumulus cell, morula blastomere NT oocytes, and in vitro‐cultured and in vivo‐recovered embryos. The mRNA expression patterns in mouse NT‐derived embryos markedly differed from in vivo and in vitro counterparts. Some transcript expression patterns in embryonic stem‐cell NT oocytes resembled those of parthenogenetic oocytes. Of the six developmentally important transcripts examined in NT embryos, four had a downregulated expression pattern at the blastocyst stage. Our findings indicate that abnormal expression patterns of development‐related genes during preimplantation development correlate with the low potential of NT oocytes to develop into young. Although more detailed information is required, Sox2 mRNA expression pattern in blastocysts seems to closely correlate with the developmental potential of NT embryos. Mol. Reprod. Dev.
- Open Access
- 1 January 2004
- Published by Japanese Society of Animal Reproduction in Journal of Reproduction and Development
- Vol. 50 (2) , 263-268
Effects of Nuclear Transfer Procedures on ES Cell Cloning Efficiency in the Mouse
Enucleated oocytes receiving mouse embryonic stem (ES) cells develop into fertile young. The developmental potential to young is low, however, and the rate of postnatal death is high. We examined the effect of various nuclear transfer procedures on the in vitro and in vivo developmental potential of nuclear-transferred oocytes. The potential of oocytes receiving ES cells at M phase to develop into blastocysts after fusion by Sendai virus was high compared with that after direct injection (67% vs. 30%). The developmental potential of oocytes receiving ES cells at the M phase is higher than that of oocytes receiving ES cells at the G1 phase (30-67% vs. 2-5%). Developmental ability to live young was low in all groups (0-4%). Different activation protocols affected the potential to develop into blastocysts to a different extent (27-62%), but did not affect the potential to develop into live young (0-3%). The present study demonstrated that the various conditions examined did not affect the potential of nuclear-transferred oocytes receiving ES cells to develop into live young or the incidence of postnatal death.
- 1 January 2004
- Published by Japanese Society of Animal Reproduction in Journal of Reproduction and Development
- Vol. 50 (2) , 263-268
Open AccessEffects of Nuclear Transfer Procedures on ES Cell Cloning Efficiency in the Mouse
Enucleated oocytes receiving mouse embryonic stem (ES) cells develop into fertile young. The developmental potential to young is low, however, and the rate of postnatal death is high. We examined the effect of various nuclear transfer procedures on the in vitro and in vivo developmental potential of nuclear-transferred oocytes. The potential of oocytes receiving ES cells at M phase to develop into blastocysts after fusion by Sendai virus was high compared with that after direct injection (67% vs. 30%). The developmental potential of oocytes receiving ES cells at the M phase is higher than that of oocytes receiving ES cells at the G1 phase (30-67% vs. 2-5%). Developmental ability to live young was low in all groups (0-4%). Different activation protocols affected the potential to develop into blastocysts to a different extent (27-62%), but did not affect the potential to develop into live young (0-3%). The present study demonstrated that the various conditions examined did not affect the potential of nuclear-transferred oocytes receiving ES cells to develop into live young or the incidence of postnatal death.
- Open Access
- 1 January 2004
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 2 (1) , 77
cDNA microarray analysis of bovine embryo gene expression profiles during the pre-implantation period
After fertilization, embryo development involves differentiation, as well as development of the fetal body and extra-embryonic tissues until the moment of implantation. During this period various cellular and molecular changes take place with a genetic origin, e.g. the elongation of embryonic tissues, cell-cell contact between the mother and the embryo and placentation. To identify genetic profiles and search for new candidate molecules involved during this period, embryonic gene expression was analyzed with a custom designed utero-placental complementary DNA (cDNA) microarray. Bovine embryos on days 7, 14 and 21, extra-embryonic membranes on day 28 and fetuses on days 28 were collected to represent early embryo, elongating embryo, pre-implantation embryo, post-implantation extra-embryonic membrane and fetus, respectively. Gene expression at these different time points was analyzed using our cDNA microarray. Two clustering algorithms such as k-means and hierarchical clustering methods identified the expression patterns of differentially expressed genes across pre-implantation period. Novel candidate genes were confirmed by real-time RT-PCR. In total, 1,773 individual genes were analyzed by complete k-means clustering. Comparison of day 7 and day 14 revealed most genes increased during this period, and a small number of genes exhibiting altered expression decreased as gestation progressed. Clustering analysis demonstrated that trophoblast-cell-specific molecules such as placental lactogens (PLs), prolactin-related proteins (PRPs), interferon-tau, and adhesion molecules apparently all play pivotal roles in the preparation needed for implantation, since their expression was remarkably enhanced during the pre-implantation period. The hierarchical clustering analysis and RT-PCR data revealed new functional roles for certain known genes (dickkopf-1, NPM, etc) as well as novel candidate genes (AW464053, AW465434, AW462349, AW485575) related to already established trophoblast-specific genes such as PLs and PRPs. A large number of genes in extra-embryonic membrane increased up to implantation and these profiles provide information fundamental to an understanding of extra-embryonic membrane differentiation and development. Genes in significant expression suggest novel molecules in trophoblast differentiation.
- 1 January 2004
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 2 (1) , 77
Open AccesscDNA microarray analysis of bovine embryo gene expression profiles during the pre-implantation period
After fertilization, embryo development involves differentiation, as well as development of the fetal body and extra-embryonic tissues until the moment of implantation. During this period various cellular and molecular changes take place with a genetic origin, e.g. the elongation of embryonic tissues, cell-cell contact between the mother and the embryo and placentation. To identify genetic profiles and search for new candidate molecules involved during this period, embryonic gene expression was analyzed with a custom designed utero-placental complementary DNA (cDNA) microarray. Bovine embryos on days 7, 14 and 21, extra-embryonic membranes on day 28 and fetuses on days 28 were collected to represent early embryo, elongating embryo, pre-implantation embryo, post-implantation extra-embryonic membrane and fetus, respectively. Gene expression at these different time points was analyzed using our cDNA microarray. Two clustering algorithms such as k-means and hierarchical clustering methods identified the expression patterns of differentially expressed genes across pre-implantation period. Novel candidate genes were confirmed by real-time RT-PCR. In total, 1,773 individual genes were analyzed by complete k-means clustering. Comparison of day 7 and day 14 revealed most genes increased during this period, and a small number of genes exhibiting altered expression decreased as gestation progressed. Clustering analysis demonstrated that trophoblast-cell-specific molecules such as placental lactogens (PLs), prolactin-related proteins (PRPs), interferon-tau, and adhesion molecules apparently all play pivotal roles in the preparation needed for implantation, since their expression was remarkably enhanced during the pre-implantation period. The hierarchical clustering analysis and RT-PCR data revealed new functional roles for certain known genes (dickkopf-1, NPM, etc) as well as novel candidate genes (AW464053, AW465434, AW462349, AW485575) related to already established trophoblast-specific genes such as PLs and PRPs. A large number of genes in extra-embryonic membrane increased up to implantation and these profiles provide information fundamental to an understanding of extra-embryonic membrane differentiation and development. Genes in significant expression suggest novel molecules in trophoblast differentiation.